RGC - Regencell Bioscience Holdings Limited -  [ ]

Ticker Details
Regencell Bioscience Holdings Limited
IPO Date: July 16, 2021
Sector: Healthcare
Industry: Drug Manufacturers
Market Cap: $14.42B
Activated in VL: True
Average Daily Range
Avg Daily Range: $3.09 | 6.64%
Avg Daily Range (30 D): $2.54 | 8.23%
Avg Daily Range (90 D): $1.89 | 6.93%
Institutional Daily Volume
Avg Daily Volume: 1.48M
Avg Daily Volume (30 D): .36M
Avg Daily Volume (90 D): .34M
Trade Size
Avg Trade Size (Sh.): 513
Avg Trade Size (Sh.) (30 D): 60
Avg Trade Size (Sh.) (90 D): 59
Institutional Trades
Total Institutional Trades: 66
Avg Institutional Trade: $.92M
Avg Institutional Trade (30 D): $.68M
Avg Institutional Trade (90 D): $.76M
Avg Institutional Trade Volume: .27M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $.75M
Avg Closing Trade (30 D): $.75M
Avg Closing Trade (90 D): $.67M
Avg Closing Volume: 82.13K
 
News
Feb 1, 2026 @ 7:31 PM
UnitedHealth, Trade Desk, And Unity Are Among Top ...
Source: Nabaparna Bhattacharya
Jan 18, 2026 @ 5:31 PM
Trip.com, Regencell Bioscience, And Atlassian Are ...
Source: Nabaparna Bhattacharya
Jan 11, 2026 @ 1:01 PM
Sandisk, Bloom Energy, And Oklo Are Among the Top ...
Source: Nabaparna Bhattacharya
Jan 8, 2026 @ 9:35 PM
Bragar Eagel & Squire, P.C. Continues Investigatio...
Source: Bragar Eagel & Squire, P.C.
Dec 24, 2025 @ 9:18 AM
How This Stock With No Revenue Returned More Than ...
Source: Dave Kovaleski
Financials
  TTM Q4 2017 FY 2017
Basic EPS $.72 $.19 $.72
Diluted EPS $.72 $.19 $.72
Revenue $3.16B $861.6M $3.16B
Gross Profit
Net Income / Loss $112.3M $28.9M $112.3M
Operating Income / Loss $271.7M $90.7M $271.7M
Cost of Revenue
Net Cash Flow $-17.7M $39.3M $-17.7M
PE Ratio 36.11    
Splits
Jun 16, 2025 38:1